HalozymeTherapeutics HALO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSIHalozyme Therapeutics HALO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange
operates under Health Care sector & deals in Biotechnology Biological Products No Diagnostic Substances
Daily price and charts and targets HalozymeTherapeutics Strong Daily Stock price targets for HalozymeTherapeutics HALO are 62.96 and 64.35 | Daily Target 1 | 61.91 | | Daily Target 2 | 62.62 | | Daily Target 3 | 63.3 | | Daily Target 4 | 64.01 | | Daily Target 5 | 64.69 |
Daily price and volume Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Fri 05 December 2025 |
63.33 (0.68%) |
62.81 |
62.59 - 63.98 |
0.6538 times |
Thu 04 December 2025 |
62.90 (-2.72%) |
63.99 |
61.06 - 66.00 |
1.0268 times |
Wed 03 December 2025 |
64.66 (-2.83%) |
66.78 |
64.50 - 67.10 |
1.2074 times |
Tue 02 December 2025 |
66.54 (-2.29%) |
68.00 |
66.38 - 68.60 |
0.7867 times |
Mon 01 December 2025 |
68.10 (-4.62%) |
71.97 |
68.01 - 72.00 |
0.9568 times |
Fri 28 November 2025 |
71.40 (-1.73%) |
72.54 |
70.49 - 72.78 |
0.4599 times |
Wed 26 November 2025 |
72.66 (-0.22%) |
72.82 |
72.17 - 74.25 |
0.5476 times |
Tue 25 November 2025 |
72.82 (-1.59%) |
74.15 |
72.27 - 74.22 |
1.0211 times |
Mon 24 November 2025 |
74.00 (5.2%) |
70.43 |
69.90 - 74.01 |
2.4146 times |
Fri 21 November 2025 |
70.34 (1.99%) |
68.97 |
68.09 - 70.76 |
0.9253 times |
Thu 20 November 2025 |
68.97 (-1.82%) |
70.58 |
68.73 - 70.81 |
0.439 times |
Weekly price and charts HalozymeTherapeutics Strong weekly Stock price targets for HalozymeTherapeutics HALO are 56.73 and 67.67 | Weekly Target 1 | 54.52 | | Weekly Target 2 | 58.93 | | Weekly Target 3 | 65.463333333333 | | Weekly Target 4 | 69.87 | | Weekly Target 5 | 76.4 |
Weekly price and volumes for Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Fri 05 December 2025 |
63.33 (-11.3%) |
71.97 |
61.06 - 72.00 |
1.2055 times |
Fri 28 November 2025 |
71.40 (1.51%) |
70.43 |
69.90 - 74.25 |
1.1565 times |
Fri 21 November 2025 |
70.34 (0.44%) |
70.51 |
68.09 - 72.71 |
0.9153 times |
Fri 14 November 2025 |
70.03 (2.62%) |
68.48 |
67.39 - 72.66 |
1.0382 times |
Fri 07 November 2025 |
68.24 (4.68%) |
67.64 |
65.00 - 70.50 |
1.8755 times |
Fri 31 October 2025 |
65.19 (0%) |
64.10 |
63.84 - 65.49 |
0.1553 times |
Fri 31 October 2025 |
65.19 (-1.45%) |
66.80 |
63.84 - 66.99 |
0.7699 times |
Fri 24 October 2025 |
66.15 (-1.31%) |
67.07 |
65.14 - 67.36 |
0.727 times |
Fri 17 October 2025 |
67.03 (4.57%) |
64.26 |
64.10 - 68.00 |
1.1308 times |
Fri 10 October 2025 |
64.10 (-7.07%) |
69.15 |
63.78 - 69.46 |
1.026 times |
Fri 03 October 2025 |
68.98 (-6.47%) |
73.75 |
68.04 - 76.30 |
1.3783 times |
Monthly price and charts HalozymeTherapeutics Strong monthly Stock price targets for HalozymeTherapeutics HALO are 56.73 and 67.67 | Monthly Target 1 | 54.52 | | Monthly Target 2 | 58.93 | | Monthly Target 3 | 65.463333333333 | | Monthly Target 4 | 69.87 | | Monthly Target 5 | 76.4 |
Monthly price and volumes Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Fri 05 December 2025 |
63.33 (-11.3%) |
71.97 |
61.06 - 72.00 |
0.2676 times |
Fri 28 November 2025 |
71.40 (9.53%) |
67.64 |
65.00 - 74.25 |
1.1068 times |
Fri 31 October 2025 |
65.19 (-11.11%) |
75.20 |
63.78 - 76.30 |
1.0613 times |
Tue 30 September 2025 |
73.34 (0.26%) |
71.78 |
71.50 - 79.50 |
1.0478 times |
Fri 29 August 2025 |
73.15 (21.98%) |
59.82 |
58.53 - 74.07 |
1.1283 times |
Thu 31 July 2025 |
59.97 (15.28%) |
51.78 |
51.78 - 61.75 |
0.7535 times |
Mon 30 June 2025 |
52.02 (-7.22%) |
55.69 |
51.06 - 56.32 |
1.4137 times |
Fri 30 May 2025 |
56.07 (-8.71%) |
61.00 |
47.50 - 70.51 |
1.7292 times |
Wed 30 April 2025 |
61.42 (-3.75%) |
64.06 |
55.71 - 64.17 |
0.7332 times |
Mon 31 March 2025 |
63.81 (7.88%) |
59.14 |
56.90 - 66.00 |
0.7586 times |
Fri 28 February 2025 |
59.15 (4.43%) |
55.12 |
54.96 - 60.67 |
0.5443 times |
DMA SMA EMA moving averages of Halozyme Therapeutics HALO
DMA (daily moving average) of Halozyme Therapeutics HALO
| DMA period | DMA value | | 5 day DMA | 65.11 | | 12 day DMA | 68.83 | | 20 day DMA | 69.24 | | 35 day DMA | 68.01 | | 50 day DMA | 68.18 | | 100 day DMA | 68.39 | | 150 day DMA | 64.05 | | 200 day DMA | 63.16 | EMA (exponential moving average) of Halozyme Therapeutics HALO
| EMA period | EMA current | EMA prev | EMA prev2 | | 5 day EMA | 65.18 | 66.11 | 67.72 | | 12 day EMA | 67.42 | 68.16 | 69.12 | | 20 day EMA | 68.13 | 68.64 | 69.24 | | 35 day EMA | 68.73 | 69.05 | 69.41 | | 50 day EMA | 68.54 | 68.75 | 68.99 |
SMA (simple moving average) of Halozyme Therapeutics HALO
| SMA period | SMA current | SMA prev | SMA prev2 | | 5 day SMA | 65.11 | 66.72 | 68.67 | | 12 day SMA | 68.83 | 69.4 | 70.03 | | 20 day SMA | 69.24 | 69.5 | 69.77 | | 35 day SMA | 68.01 | 68.11 | 68.21 | | 50 day SMA | 68.18 | 68.39 | 68.65 | | 100 day SMA | 68.39 | 68.33 | 68.27 | | 150 day SMA | 64.05 | 64.03 | 64.02 | | 200 day SMA | 63.16 | 63.13 | 63.1 |
|
|
